Sökning: "Colorectal cancer"
Visar resultat 1 - 5 av 372 avhandlingar innehållade orden Colorectal cancer.
1. Colorectal Cancer : Audit and Health Economy in Colorectal Cancer Surgery in a Defined Swedish Population
Sammanfattning : Colorectal cancer is one of the most common malignancies in Sweden, with more than 5000 new cases annually. Median age at time of diagnosis is approximately 75 years. Owing to the ageing population, the incidence of colorectal cancer is increasing. LÄS MER
2. Risk and survival for colorectal cancer in northern Sweden : sociodemographic factors and surveillance programs
Sammanfattning : BackgroundColorectal cancer (CRC) – i.e., cancer in the colon or rectum – is one of the most common cancers both globally and in Sweden. The risk for CRC is mainly related to age, heredity, and life-style risk factors. LÄS MER
3. Colorectal cancer : patients’ and next-of-kin’s experiences and the effects of a psycho-educational program
Sammanfattning : Purpose: To test whether a psycho-educational program affects mental wellbeing in persons treated for colorectal cancer and their next-of-kin.Design: A prospective, longitudinal, randomized controlled trial.Setting: Surgical clinic at a university hospital in Sweden. LÄS MER
4. Hereditary Nonpolyposis Colorectal Cancer - Molecular Genetics and Biology of Associated Tumors
Sammanfattning : This thesis focuses on one of the most common types of hereditary cancer, hereditary nonpolyposis colorectal cancer (HNPCC). This syndrome is characterized by an autosomal dominant inheritance, an increased risk for several types of cancer (especially cancer of the colorectum, small bowel, endometrium, ovary and urinary tract), early age at diagnosis, and frequent development of multiple primary malignancies. LÄS MER
5. Type IV collagen in breast and colorectal cancer : a potential biomarker of metastatic disease
Sammanfattning : Background: Metastatic colorectal cancer (mCRC) and metastatic breast cancer (mBC) are two leading causes of cancer-related mortality worldwide. Early detection of metastatic disease is critical, and sensitive, easily accessed and cost-effective biomarkers that can diagnose mBC and mCRC at an early stage would have high clinical value. LÄS MER